{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T18:24:54Z","timestamp":1748715894722},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,29]],"date-time":"2015-09-29T00:00:00Z","timestamp":1443484800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","krcp-ksn.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Research and Clinical Practice"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.krcp.2015.09.003","type":"journal-article","created":{"date-parts":[[2016,1,23]],"date-time":"2016-01-23T02:20:41Z","timestamp":1453515641000},"page":"182-186","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Rhabdomyolysis in a patient taking nebivolol"],"prefix":"10.1016","volume":"35","author":[{"given":"Ye Jin","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hae Ri","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong Jae","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun Jun","family":"Ju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dae Eun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kang Wook","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki Ryang","family":"Na","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.krcp.2015.09.003_bib1","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1056\/NEJMra0801327","article-title":"Rhabdomyolysis and acute kidney injury","volume":"361","author":"Bosch","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.krcp.2015.09.003_bib2","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1681\/ASN.V1181553","article-title":"Rhabdomyolysis","volume":"11","author":"Vanholder","year":"2000","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.krcp.2015.09.003_bib3","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ahj.2009.12.008","article-title":"Propranolol and the risk of hospitalized myopathy: translating chemical genomics findings into population-level hypotheses","volume":"159","author":"Setoguchi","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.krcp.2015.09.003_bib4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0887-8994(90)90122-H","article-title":"Reversible myopathy due to labetalol","volume":"6","author":"Willis","year":"1990","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.krcp.2015.09.003_bib5","first-page":"103","article-title":"Pindolol-induced rhabdomyolysis in sarcoid myopathy","volume":"30","author":"Aihara","year":"1990","journal-title":"Rinsho shinkeigaku"},{"key":"10.1016\/j.krcp.2015.09.003_bib6","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1365-2125.1990.tb03834.x","article-title":"Selective beta-adrenoceptor partial agonist effects of pindolol and xamoterol on skeletal muscle assessed by plasma creatine kinase changes in healthy subjects","volume":"30","author":"Tomlinson","year":"1990","journal-title":"Br\u00a0J Clin Pharmacol"},{"key":"10.1016\/j.krcp.2015.09.003_bib7","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/00005344-198805000-00007","article-title":"Pharmacological and hemodynamic profile of nebivolol, a chemically novel, potent, and selective beta 1-adrenergic antagonist","volume":"11","author":"Van de Water","year":"1988","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.krcp.2015.09.003_bib8","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.jacc.2009.05.066","article-title":"Nebivolol: the somewhat-different beta-adrenergic receptor blocker","volume":"54","author":"Munzel","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.krcp.2015.09.003_bib9","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1023\/A:1007760515117","article-title":"Nebivolol: comparison of the effects of dl-nebivolol, d-nebivolol, l-nebivolol, atenolol, and placebo on exercise-induced increases in heart rate and systolic blood pressure","volume":"12","author":"Van Nueten","year":"1998","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.krcp.2015.09.003_bib10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1755-5922.2008.00054.x","article-title":"Nebivolol: a highly selective beta1-adrenergic receptor blocker that causes vasodilation by increasing nitric oxide","volume":"26","author":"Gupta","year":"2008","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.krcp.2015.09.003_bib11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2165\/00129784-200808010-00005","article-title":"Efficacy and tolerability of nebivolol compared with other antihypertensive drugs: a meta-analysis","volume":"8","author":"Van Bortel","year":"2008","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.krcp.2015.09.003_bib12","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/eurheartj\/ehs092","volume":"33","author":"Perk","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.krcp.2015.09.003_bib13","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1161\/01.CIR.101.2.207","article-title":"Current perspectives on statins","volume":"101","author":"Maron","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.krcp.2015.09.003_bib14","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2165\/00002018-200022060-00003","article-title":"HMG-CoA reductase inhibitors and myotoxicity","volume":"22","author":"Ucar","year":"2000","journal-title":"Drug Saf"},{"key":"10.1016\/j.krcp.2015.09.003_bib15","doi-asserted-by":"crossref","first-page":"C1208","DOI":"10.1152\/ajpcell.00226.2006","article-title":"Statin-induced apoptosis and skeletal myopathy","volume":"291","author":"Dirks","year":"2006","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.krcp.2015.09.003_bib16","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.amjcard.2004.10.012","article-title":"Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial)","volume":"95","author":"Grundy","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.krcp.2015.09.003_bib17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2165\/11533430-000000000-00000","article-title":"Efficacy and safety of rosuvastatin and fenofibric acid combination therapy versus simvastatin monotherapy in patients with hypercholesterolemia and hypertriglyceridemia","volume":"10","author":"Roth","year":"2010","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.krcp.2015.09.003_bib18","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.amjmed.2006.02.007","article-title":"Clinical perspectives of statin-induced rhabdomyolysis","volume":"119","author":"Antons","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.krcp.2015.09.003_bib19","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jacc.2007.02.073","article-title":"Effect of the magnitude of lipid lowering on risk of elevated liver enzymes, rhabdomyolysis, and cancer: insights from large randomized statin trials","volume":"50","author":"Alsheikh-Ali","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.krcp.2015.09.003_bib20","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jama.292.11.1307","article-title":"Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial","volume":"292","author":"de Lemos","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.krcp.2015.09.003_bib21","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/00005176-199005000-00020","article-title":"Nonocclusive mesenteric ischemia associated with propranolol overdose: implications regarding splanchnic circulation","volume":"10","author":"Pettei","year":"1990","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.krcp.2015.09.003_bib22","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/j.1552-4604.1996.tb04247.x","article-title":"Acebutolol overdose treated with hemodialysis and extracorporeal membrane oxygenation","volume":"36","author":"Rooney","year":"1996","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.krcp.2015.09.003_bib23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/096032718500400106","article-title":"Recovery after severe oxprenolol overdose complicated by rhabdomyolysis","volume":"4","author":"Schofield","year":"1985","journal-title":"Hum Toxicol"},{"key":"10.1016\/j.krcp.2015.09.003_bib24","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1152\/physrev.00028.2007","article-title":"Role of beta-adrenoceptor signaling in skeletal muscle: implications for muscle wasting and disease","volume":"88","author":"Lynch","year":"2008","journal-title":"Physiol Rev"},{"key":"10.1016\/j.krcp.2015.09.003_bib25","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1136\/bmj.2.6140.833-b","article-title":"Muscle cramp and oral salbutamol","volume":"2","author":"Palmer","year":"1978","journal-title":"BMJ"},{"key":"10.1016\/j.krcp.2015.09.003_bib26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2165\/00151642-200512010-00005","article-title":"Tolerability of nebivolol in head-to-head clinical trials versus other cardioselective \u03b2-blockers in the treatment of hypertension","volume":"12","author":"Ambrosioni","year":"2005","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"10.1016\/j.krcp.2015.09.003_bib27","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.amjcard.2012.11.031","article-title":"Meta-analysis of carvedilol versus beta 1 selective beta-blockers (atenolol, bisoprolol, metoprolol, and nebivolol)","volume":"111","author":"DiNicolantonio","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.krcp.2015.09.003_bib28","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1067\/mhj.2001.115584","article-title":"Comparative effects of carvedilol and metoprolol on left ventricular ejection fraction in heart failure: results of a meta-analysis","volume":"141","author":"Packer","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.krcp.2015.09.003_bib29","first-page":"101","article-title":"Nebivolol, a third generation novel beta-blocker, systematic review","volume":"1","author":"Cleophas","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.krcp.2015.09.003_bib30","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.cardfail.2011.05.001","article-title":"Comparative long term effects of nebivolol and carvedilol in hypertensive heart failure patients","volume":"17","author":"Marazzi","year":"2011","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.krcp.2015.09.003_bib31","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/sj.bjp.0705823","article-title":"Attenuation of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-induced rhabdomyolysis with alpha1- plus beta3-adrenoreceptor antagonists","volume":"142","author":"Sprague","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.krcp.2015.09.003_bib32","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1097\/01.CCM.0000165969.29002.70","article-title":"Carvedilol reverses hyperthermia and attenuates rhabdomyolysis induced by 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) in an animal model","volume":"33","author":"Sprague","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1016\/j.krcp.2015.09.003_bib33","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1756-0500-6-52","article-title":"Case report of exercise and statin-fibrate combination therapy-caused myopathy in a patient with metabolic syndrome: contradictions between the two main therapeutic pathways","volume":"6","author":"L\u00e1szl\u00f3","year":"2013","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.krcp.2015.09.003_bib34","first-page":"1096","article-title":"Rhabdomyolysis and HMG-CoA reductase inhibitors","volume":"35","author":"Omar","year":"2001","journal-title":"Ann Pharm"},{"key":"10.1016\/j.krcp.2015.09.003_bib35","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nbt1387","article-title":"Large-scale chemical dissection of mitochondrial function","volume":"26","author":"Wagner","year":"2008","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.krcp.2015.09.003_bib36","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/clinids\/22.4.642","article-title":"Infectious etiologies of rhabdomyolysis: three case reports and review","volume":"22","author":"Singh","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.krcp.2015.09.003_bib37","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1148\/radiographics.13.4.8356264","article-title":"Extraosseous Tc-99m MDP uptake: a pathophysiologic approach","volume":"13","author":"Peller","year":"1993","journal-title":"Radiographics"},{"key":"10.1016\/j.krcp.2015.09.003_bib38","first-page":"149","article-title":"Nonosseous abnormalities on bone scans","volume":"31","author":"Loutfi","year":"2003","journal-title":"J\u00a0Nucl Med Technol"},{"key":"10.1016\/j.krcp.2015.09.003_bib39","first-page":"153","article-title":"Increased uptake of\u00a0technetium-99m methylene diphosphonate in muscles in the\u00a0course of polymyositis","volume":"8","author":"Niemir","year":"2005","journal-title":"Nucl Med Rev Cent East Eur"},{"key":"10.1016\/j.krcp.2015.09.003_bib40","first-page":"309","article-title":"An unexpected, benign cause of increased muscular uptake at bone scintigraphy","volume":"12","author":"Lafforgue","year":"1994","journal-title":"Clin Exp Rheumatol"}],"container-title":["Kidney Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211913215300024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211913215300024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T07:39:24Z","timestamp":1654155564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211913215300024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S2211913215300024"],"URL":"https:\/\/doi.org\/10.1016\/j.krcp.2015.09.003","relation":{},"ISSN":["2211-9132"],"issn-type":[{"value":"2211-9132","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rhabdomyolysis in a patient taking nebivolol","name":"articletitle","label":"Article Title"},{"value":"Kidney Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.krcp.2015.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016. The Korean Society of Nephrology. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}